Nkarta Inc (NASDAQ: NKTX)’s stock price has plunge by 9.96relation to previous closing price of 2.61. Nevertheless, the company has seen a 14.80% surge in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-26 that SOUTH SAN FRANCISCO, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:
Is It Worth Investing in Nkarta Inc (NASDAQ: NKTX) Right Now?
The 36-month beta value for NKTX is at 0.80. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 4 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NKTX is 46.00M, and currently, shorts hold a 14.72% of that float. The average trading volume for NKTX on November 27, 2024 was 789.29K shares.
NKTX’s Market Performance
The stock of Nkarta Inc (NKTX) has seen a 14.80% increase in the past week, with a -15.84% drop in the past month, and a -47.82% fall in the past quarter. The volatility ratio for the week is 5.75%, and the volatility levels for the past 30 days are at 8.59% for NKTX. The simple moving average for the last 20 days is -0.30% for NKTX stock, with a simple moving average of -56.39% for the last 200 days.
Analysts’ Opinion of NKTX
Many brokerage firms have already submitted their reports for NKTX stocks, with Rodman & Renshaw repeating the rating for NKTX by listing it as a “Buy.” The predicted price for NKTX in the upcoming period, according to Rodman & Renshaw is $14 based on the research report published on October 09, 2024 of the current year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see NKTX reach a price target of $16. The rating they have provided for NKTX stocks is “Strong Buy” according to the report published on August 14th, 2024.
Raymond James gave a rating of “Outperform” to NKTX, setting the target price at $16 in the report published on March 22nd of the current year.
NKTX Trading at -20.94% from the 50-Day Moving Average
After a stumble in the market that brought NKTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.33% of loss for the given period.
Volatility was left at 8.59%, however, over the last 30 days, the volatility rate increased by 5.75%, as shares sank -14.59% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.03% lower at present.
During the last 5 trading sessions, NKTX rose by +13.77%, which changed the moving average for the period of 200-days by -72.82% in comparison to the 20-day moving average, which settled at $2.88. In addition, Nkarta Inc saw -56.52% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NKTX starting from Hager Alicia J., who sale 3,396 shares at the price of $8.00 back on Jul 16 ’24. After this action, Hager Alicia J. now owns 103,819 shares of Nkarta Inc, valued at $27,168 using the latest closing price.
Trager James, the Chief Scientific Officer of Nkarta Inc, sale 456 shares at $5.60 during a trade that took place back on Jun 18 ’24, which means that Trager James is holding 150,959 shares at $2,554 based on the most recent closing price.
Stock Fundamentals for NKTX
Current profitability levels for the company are sitting at:
- -12.19 for the present operating margin
- 0.36 for the gross margin
The net margin for Nkarta Inc stands at -10.49. The total capital return value is set at -0.25. Equity return is now at value -30.40, with -23.59 for asset returns.
Currently, EBITDA for the company is -120.48 million with net debt to EBITDA at -0.25. When we switch over and look at the enterprise to sales, we see a ratio of 21.71. The liquidity ratio also appears to be rather interesting for investors as it stands at 12.91.
Conclusion
In conclusion, Nkarta Inc (NKTX) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
